n (%) | |
---|---|
Gender | |
Male | 15 (47) |
Female | 17 (53) |
Age (median, range) | 66, 34–84 |
Performance status | |
0/1/2/3/4 | 7/14/7/3/1 |
Primary site | |
Lung | 11 (34) |
Breast | 10 (31) |
Head and neck | 7 (22) |
Other | 4 (13) |
Pathology | |
Squamous cell carcinoma | 11 (34) |
Ductal carcinoma | 9 (28) |
Adenocarcinoma | 4 (13) |
Small cell carcinoma | 2 (6) |
Others | 3 (9) |
Unknown | 3 (9) |
Radiation dose (Gy) | |
Median (range) | 50 (15–72) |
Radiation intent | |
Radical | 8 (26) |
Semi-radical | 3 (9) |
Postoperative | 10 (31) |
Palliative | 11 (34) |
Chemotherapy (Yes/No) | 8/24 |